Arcus Biosciences Inc (RCUS)
Debt-to-assets ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total assets | US$ in thousands | 1,150,000 | 1,252,000 | 1,186,000 | 1,293,000 | 1,095,000 | 1,191,000 | 1,220,000 | 1,254,000 | 1,345,000 | 1,393,820 | 1,476,770 | 1,543,430 | 1,592,000 | 839,290 | 898,773 | 935,119 | 772,292 | 811,075 | 481,389 | 176,144 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,150,000K
= 0.00
The debt-to-assets ratio for Arcus Biosciences Inc has remained consistently at 0.00 for the period ranging from March 31, 2020, to December 31, 2024. A debt-to-assets ratio of 0.00 indicates that the company has no debt in relation to its total assets during this time frame. This signifies that the company has been financing its operations primarily through equity or other non-debt sources, leading to a strong financial position with no debt burden. It suggests a lower financial risk for the company, as it does not rely heavily on borrowing to fund its operations and investments.
Peer comparison
Dec 31, 2024